Lyra therapeutics announces appointment of ronan o'brien as chief legal officer

Watertown, mass., oct. 16, 2023 (globe newswire) -- lyra therapeutics, inc. (nasdaq: lyra) (“lyra” or the “company”), a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (“crs”), today announced the appointment of ronan o'brien, as chief legal officer, effective october 16, 2023.
LYRA Ratings Summary
LYRA Quant Ranking